The most important gatherings of ASEAN's pharmaceutical industry

 

A leading pharmaceutical solutions event, where a trade show on products, technologies, innovations, seminars on raw materials, pharmaceutical ingredients and packaging, technologies in pharmaceutical production, business matching, medical supplies, and much more, is to happen to promote the pharmaceutical industry and herbal medicines in South East Asia.

No matter where you are in the pharmaceutical supply chain, CPHI South East Asia is your ultimate one-stop shop to find the latest pharma solutions.

One Event - More Experiences

With the increasing need for the industry to regroup, we will concentrate our efforts on ensuring a thriving and successful comeback show that gives you the second-to-none business opportunities you have come to expect from our event.

Source

Source products and services from SEA’s most inventive pharma solution providers, helping you forge new partnerships and take your business to the next level.

Networking

With an expected 8,000 local and regional pharma professionals, you can find solutions, solve problems and connect with world-class suppliers.

Learn

The latest innovations, technologies, trends and developments in the regional pharmaceutical industry across a wide range of conferences, exhibitor showcases and other exciting onsite features.



Our community

More Than An Exhibition

CPHI South East Asia will be your one-stop shop to source cost-effective pharma solutions under one roof. More than an exhibition, the event also facilitates finding the right partners with its business matchmaking tool and encourages knowledge gathering and many more in CPHI SEA 2023.

8,000+

Visitors

300+

Exhibitors

40+

Countries

40+

Seminars




Message from ASEAN Informa Markets-Thailand

 

“Thailand was one of the leading pharmaceutical markets in Southeast Asia. Over 2022 and 2023, annual growth in the market should accelerate to 3.5% due to rising concerns among Thais over personal health and wellness, partly a side-effect of the Covid-19 pandemic and the ageing of Thai society. Furthermore, the government has determined the pharmaceutical industry as one of the “New S-curve” groups which could potentially create added value for the country. The domestic pharmaceutical market value at approximately 1.8 hundred billion Baht makes Thailand the second largest market in Southeast Asia after Indonesia.”

Rungphech Chitanuwat - Regional Portfolio Director

Last Edition Hightlights

What People Said

"OLIC as CMO we appreciated that CPHI SEA is back after 2 years absence due to COVID-19 situation. Thank to CPHI, we have great opportunity to meet our business partners, as well as our future business collaborators from machinery, software services and materials. And we do hope to get Moving Together with Trust with all we met here at CPHI SEA 2022."

 

 

Alessandro Gagnoni
Senior Director Pharmaceutical Operations, Kamfarma SA

"Thank you to CPHI that allowing us opportunity to update ourselves knowledge with pharmaceutical regulations in ASEAN, as pharmaceutical experts are invited to share several issues and developments during an educational seminar especially the halal pharmaceutical industry session to let’s us understand more and more on the ASEAN Halal concepts."

 

Ms. Panita Norani-tiphadungkarn
CMO- Mednova (Thailand)